2Naughton GK, Reggiardo D, Bystryn JC. Correlation between vitiligo antibodies and extent of depigmentation in vitiligo. J Am Acad Dermatol, 1986, 15(5 Pt 1 ): 978-981.
3Steitz J,Wenzel J, Gaffal E, et al. Initiation and regulation of CD8^+ T cells recognizing melanocytic antigens in the epidermis: implications for the pathophysiology of vitiligo. Eur J Cell Biol, 2004, 83(11-12): 797-803.
4Hirobe T. Role of keratinocyte-derived factors involved in regulating the proliferation and differentiation of mammalian epidermal melanocytes. Pigment Cell Res, 2005, 18( 1 ): 2-12.
5Oliveira SH, Lukacs NW. Stem cell factor: a hemopoietic cytokine with important targets in asthma. Curr Drug Targets Inflamm Allergy, 2003, 2(4): 313-318.
6Kunisada T, Yamazaki H, Hayashi SI. Review: ligands for receptor tyrosine kinases expressed in the skin as environmental factors for melanocyte development.J Investig Dermatol Symp Proc, 2001, 6( 1 ): 6-9.
7Okura M, Maeda H, Nishikawa S, et al. Effects of monoclonal anti-c-kit antibody (ACK2) on melanocytes in newborn mice. J Invest Dermatol, 1995, 105(3): 322-328.
8Lan CC, Chen GS, Chiou MH, et al. FK506 promotes melanocyte and melanoblast growth and creates a favourable milieu for cell migration via keratinocytes: possible mechanisms of how tacrolimus ointment induces repigmentation in patients with vitiligo. Br J Dermatol, 2005, 153(3): 498-505.
